Novogene Co., Ltd.

Novogene Co., Ltd. experienced notable stock activity, gaining 7.19% on July 1, 2026, amid a modest rise in the China Shanghai Composite. While the company has shown short-term gains, its long-term growth remains challenged, with a five-year annual net sales increase of 4.65% and a year-over-year decline of 5.56%.

Novogene Co., Ltd. has faced a significant stock price decline, reaching an intraday low amid ongoing performance challenges. Over the past week and month, the stock has shown negative trends, contrasting with the more stable performance of the China Shanghai Composite. Long-term metrics indicate substantial underperformance relative to the benchmark.

Novogene Co., Ltd. has experienced notable short-term gains, with a 6.51% increase on May 25, 2026. Despite long-term challenges, the company has shown a year-to-date performance of 18.22%. Key financial metrics include a P/E ratio of 36.00 and a return on equity of 5.86%.